Todd Zavodnick, Dermavant CEO

With top­i­cal ap­proval, Der­ma­vant looks to bring new stan­dard-of-care to plaque pso­ri­a­sis pa­tients

Der­ma­vant CEO Todd Za­vod­nick has been plot­ting to up­end the plaque pso­ri­a­sis mar­ket for years now. And with the com­pa­ny’s first ap­proval on Tues­day, he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.